Second Sight Medical Products Inc
EYES - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.75M
Close$
$7.52
74.8% downside
Current Fair Value
74.8% downsideOvervalued by 74.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.75 Million |
|---|---|
| Enterprise Value | $1.71 Million |
| Earnings per Share | $- |
| Beta | 5.14 |
| Outstanding Shares | - |
Return
| Return on Equity | -138.73% |
|---|---|
| Return on Assets | -63.19% |
| Return on Invested Capital | -77.84% |
Valuation & Multiples
| P/E Ratio | -75 |
|---|---|
| PEG | 692.25 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.06 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 10.43 |
| Debt to Equity | 0.94 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Second Sight Medical Products Inc
12 employees
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulatio...